The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times

Ítems similars

• The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke
  per: Goebel, Silvia, et al.
  Publicat: (2013)
• Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke
  per: Reimann, Andreas, et al.
  Publicat: (2016)
• Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
  per: Jamasbi, Janina, et al.
  Publicat: (2015)
• Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation
  per: Jamasbi, Janina, et al.
  Publicat: (2016)
• Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
  per: Ungerer, Martin, et al.
  Publicat: (2016)